News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Conference News THT 2025 Positive Results With Carillon Mitral Device Seen in Real-world Registries Todd Neale February 21, 2025
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Daily News Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details Michael O'Riordan January 25, 2024
News Daily News Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All Michael O'Riordan September 18, 2023
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022
News Conference News STS 2022 Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression Michael O'Riordan February 04, 2022
News Conference News STS 2022 Modified Surgical MV Repair Stands Up to Replacement Michael O'Riordan February 03, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Conference News TVT 2020 MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT Michael O'Riordan June 21, 2020
News Opinion Editor's Corner TCT 2018 TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights Shelley Wood September 23, 2018
News Conference News CRT 2018 Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR Michael O'Riordan March 05, 2018
Presentation TVT 2013 Impact of Function MR on Outcomes in Ischemic and Idiopathic Dilated Cardiomyopathy: Major Culprit or Innocent Bystander? Presenter: Maurice Sarano June 14, 2013